课题基金 / 基金详情

项目摘要

项目成果

Keith C Norris的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):Charles R. Drew医学与科学大学提议共同主办第九届国际弱势群体肾脏疾病会议:国际肾脏病学会(ISN)/世界肾脏病大会(WCN) 2013的卫星会议,将于6月4日至6日在香港举行,以及随后的2015年(智利)和2017年(TBD) WCN会议。这些会议是与弱势群体肾脏健康委员会(CKHDP)联合主办的,CKHDP是ISN全球外展计划的一个小组委员会。CKHDP的使命是改善发展中国家和发达国家中遭受慢性肾脏疾病(CKD)危险因素、CKD及其并发症的弱势群体的健康。我们建议使用赠款资金为参加会议的年轻教师和初级研究人员(在科学领域代表性不足)提供支持,并每隔一年支持会议规划和会议论文集的出版。2013年的会议将重点关注发展中国家的慢性肾病,以及西方化国家的少数民族、移民和弱势群体,将有精心挑选的全球参与者和来自世界各地的抽象报告,其中包括美国的初级研究人员,重点是支持那些传统上在科学领域代表性不足的人。主要议题将包括CKD和终末期肾脏疾病的病因和流行情况,以及它们在发展中国家的危险因素和并发症。会议还将重点讨论具有成本效益的创新预防和早期治疗策略。本次研讨会的首要目标是让来自发展中国家的肾病学家、在科学领域未被充分代表的美国初级教师和成熟的临床医生/科学家之间的互动,暴露和促进与肾脏疾病及其危险因素和并发症相关的新兴问题,这些问题困扰着世界各地的弱势社区和种族/少数民族群体。组委会将从会议资助基金中提供最多30个奖学金,以支持选定的获奖者(例如妇女、种族/少数民族、残疾人、其他传统上在科学领域代表性不足的个人)参加卫星会议,并提供免费注册和住宿。为了有资格获得NIH会议基金,每位接受者必须提交至少一篇会议摘要,并且必须是来自美国的初级研究员,在科学领域的代表性不足。本申请的目标是:目标1:为传统上在科学领域代表性不足的初级研究人员提供更多机会,参加以弱势社区CKD预防和早期治疗为重点的卫星研讨会。目标2:在弱势社区增加知识转移和促进创新CKD预防和早期治疗策略的科学发现。
英文摘要
DESCRIPTION (provided by applicant): Charles R. Drew University of Medicine and Science proposes to co-sponsor the 9th International Conference on Kidney Disease in Disadvantaged Populations: a satellite meeting of the International Society of Nephrology (ISN)/World Congress of Nephrology (WCN) 2013 to be held June 4-6 in Hong Kong, and the subsequent 2015 (Chile) and 2017 (TBD) WCN meetings. These are jointly sponsored meetings with the Committee for Kidney Health in Disadvantaged Populations (CKHDP), a sub-committee of the ISN Global Outreach Program. The mission of CKHDP is to improve the health of disadvantaged communities in both the developing and developed world that suffer disproportionately from chronic kidney disease (CKD) risk factors, CKD, and its complications. We propose to use grant funds to provide support for young faculty and junior investigators (underrepresented in science) attending the meeting, and on alternate years to support conference planning and the publication of conference proceedings. The 2013 meeting will focus on CKD in developing countries, and on minority, migrant, and disadvantaged groups in westernized countries, with carefully selected global participants and abstract presentations from around the world, including by junior US investigators with an emphasis on supporting those traditionally underrepresented in science. Main topics will include etiology and prevalence of CKD and end stage renal disease, as well as their risk factors and complications in the context of developing nations. The conference also will focus on innovative cost effective prevention and early treatment strategies. The symposium's overarching goal is to expose and facilitate interactions between nephrologists from developing countries, US junior faculty underrepresented in science and established clinician/scientists to the burgeoning problems that beset disadvantaged communities and racial/ethnic minority groups worldwide, as related to kidney disease and its risk factors and complications. The organizing committee will provide up to 30 scholarships from conference grant funds to support selected recipients (e.g. women, racial/ethnic minorities, persons with disabilities, other individuals who have been traditionally underrepresented in science) to attend the satellite meeting with complimentary registration and accommodations. To be eligible for NIH conference funds, each recipient must submit at least one abstract for the conference and be a junior investigator from the US, underrepresented in science. The objectives of this application are to: Objective 1: Provide increased access for junior investigators traditionally underrepresented in science to attend a satellite symposium focusing on CKD prevention and early treatment in disadvantaged communities. Objective 2: Increase knowledge transfer and stimulate scientific discovery around innovative CKD prevention and early treatment strategies in disadvantaged communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Community Engagement Core
Community Engagement Core
Community Engagement Core
UCLA Short-Term Research Experience to Unlock Potential (UCLA STEP-UP)
海外基金